نتائج البحث

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

• Authors : National Cancer Institute (NCI)

• Source: Timed Sequential Busulfan and Post Transplant Cyclophosphamide for Allogeneic Transplantation

تفاصيل العنوان

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

• Authors : medac GmbH

• Source: Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen

تفاصيل العنوان

Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

• Authors : National Cancer Institute (NCI)

• Source: Allogeneic Transplantation Using Venetoclax, Timed Sequential Busulfan,Cladribine, and Fludarabine Conditioning in Patients with AML and

تفاصيل العنوان

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

• Source: Allogeneic Hematopoietic Cell Transplantation for Patients With Non-Malignant Disorders Using Treosulfan, Fludarabine, and Thiotepa

تفاصيل العنوان

Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

• Authors : National Cancer Institute (NCI)

• Source: Phase I/II Study of Sorafenib Added to Busulfan and Fludarabine Conditioning Regimen in Patients With Relapsed/Refractory AML Undergoing

تفاصيل العنوان

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

• Authors : National Institutes of Health (NIH); Jacqueline Garcia, MD, Principal Investigator

• Source: A Phase 1 Study of Adding Venetoclax to a Reduced Intensity Conditioning Regimen and to Maintenance in Combination With a Hypomethylating Agent After Allogeneic Hematopoietic Cell Transplantation for

تفاصيل العنوان

Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

• Authors : Damiano Rondelli, MD, Professor, Hematology

• Source: A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic

تفاصيل العنوان

Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) (FluBuBe)

• Authors : Ivan S Moiseev, Vice-pdirector for science RM Gorbacheva Institute

• Source: Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

تفاصيل العنوان

Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

• Authors : Jiong HU, Head, Blood & Marrow Transplantation Center, Rui Jin Hospital

• Source: Multiple-center Randomized Study to Compare Fludarabine and Busulfan Versus Fludarabine,

تفاصيل العنوان

PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

• Source: PRO#1278: A Phase III Study of Fludarabine and Busulfan Versus Fludarabine,

تفاصيل العنوان